Organization · Venture Capital
WR Hambrecht + Co
WR Hambrecht + Co is an investment banking firm based in San Francisco, specializing in innovative capital raising methods and early growth capital for disruptive companies, particularly in technology and healthcare.
Overview
What WR Hambrecht + Co does
What WR Hambrecht + Co is
WR Hambrecht + Co is an investment banking firm based in San Francisco, specializing in innovative capital raising methods and early growth capital for disruptive companies, particularly in technology and healthcare.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 1998
- Approximate age
- About 28 years
- Structured capabilities
- Funder
- Last reviewed
- April 29, 2026
Official channels
Find WR Hambrecht + Co elsewhere
Open the official website or a supported primary organization account.
Capability profile
WR Hambrecht + Co as a funder
Investment thesis
WR Hambrecht + Co focuses on identifying and investing in early disruptive companies, particularly in technology and healthcare sectors, guided by Disruption Theory to target underserved markets.
Focus narrative
The firm targets early-stage investments in disruptive companies, particularly in technology and healthcare. Their investment strategy is informed by Disruption Theory, emphasizing lower-cost market segments and underserved customers. WR Hambrecht + Co has launched multiple venture funds, including generalist and healthcare-focused funds, to support this strategy.
Value beyond capital
WR Hambrecht + Co adds value to its portfolio companies by leveraging decades of venture experience and a proprietary computing system that provides insights into private markets. The firm supports its companies in accessing capital and navigating growth strategies, including potential public-market opportunities through its capital-markets expertise.
Focus and fit
- Stages
- Seed · Series A · Growth Equity
- Regions
- Global · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 500
- Recorded notable exits
- Color Health
Portfolio context
Notable portfolio companies include: Tasso: Developed a virtually painless blood collection device for self-collection of blood samples. Color Health: Provides technology and infrastructure for large-scale health initiatives, including population genomics and COVID-19 testing. FUV (Arcimoto): Manufacturer of affordable, small-footprint electric vehicles. Proov: Focuses on at-home fertility and menstrual cycle diagnostics. Tango: A live streaming app with a global user base. PatientsLikeMe: A personalized health network that connects individuals with treatments and support.
Common questions
What to know about WR Hambrecht + Co
Upseed classifies WR Hambrecht + Co under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 29, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.